Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children

Data Availability

Data associated with this study are present in the paper or appendix and will be available after the end of the study upon reasonable request that should be directed to the corresponding author. Proposals will be reviewed and approved by the Sponsor, Chief Investigator, and collaborators. After approval of a proposal, data can be shared through a secure online platform after signing a data access agreement. Any shared data will be de-identified.